Massimo Ghizzoni
Impact in
-
- Histone Deacetylase Inhibitors Research
- Epigenetics and DNA Methylation
- Genomics and Chromatin Dynamics
- Protein Degradation and Inhibitors
- Cancer-related gene regulation
Papers in
-
- Histone Deacetylase Inhibitors Research 5
- Enzyme function and inhibition 1
- Protein Degradation and Inhibitors 1
-
- Protease and Inhibitor Mechanisms 1
- Co-authors
- Frank J. Dekker (9 shared papers)Hidde J. Haisma (7 shared papers)Harm Maarsingh (2 shared papers)André Boltjes (2 shared papers)Tielong Gao (1 shared paper)Jiang Wu (1 shared paper)Rosalina Wisastra (3 shared papers)Chris de Graaf (1 shared paper)
- Journals
- Bioorganic & Medicinal Chemistry (3 papers)European Journal of Medicinal Chemistry (2 papers)APOPTOSIS (1 paper)Anti-Cancer Agents in Medicinal Chemistry (1 paper)Drug Discovery Today (1 paper)
- Partner nations
- NetherlandsPolandIreland
In The Last Decade
Massimo Ghizzoni
9 papers receiving 442 citations
Peers
Comparison fields: 5 of 67
- Molecular Biology 269
- Geriatrics and Gerontology 11
- Cancer Research 29
- Biochemistry 13
- Molecular Medicine 10
Countries citing papers authored by Massimo Ghizzoni
This map shows the geographic impact of Massimo Ghizzoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Ghizzoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Ghizzoni more than expected).
Fields of papers citing papers by Massimo Ghizzoni
This network shows the impact of papers produced by Massimo Ghizzoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Ghizzoni. The network helps show where Massimo Ghizzoni may publish in the future.
Co-authors
The 16 scholars most cited alongside Massimo Ghizzoni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 117 | |
| 2 | 2011 | 109 | |
| 3 | 2010 | 74 | |
| 4 | 2008 | 49 | |
| 5 | 2009 | 33 | |
| 6 | 2012 | 25 | |
| 7 | 2011 | 21 | |
| 8 | 2013 | 14 | |
| 9 | 2012 | 11 |
About Massimo Ghizzoni
Massimo Ghizzoni is a scholar working on Molecular Biology, Cancer Research, Biochemistry, Hematology and Pharmacology, having authored 9 papers that have together received 453 indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (5 papers), Enzyme function and inhibition (1 paper), Protease and Inhibitor Mechanisms (1 paper), Inflammatory mediators and NSAID effects (1 paper), Eicosanoids and Hypertension Pharmacology (1 paper), Chronic Myeloid Leukemia Treatments (1 paper), Click Chemistry and Applications (1 paper) and Protein Degradation and Inhibitors (1 paper). The work is most often cited by research in Molecular Biology (269 citations), Geriatrics and Gerontology (11 citations), Cancer Research (29 citations), Biochemistry (13 citations) and Molecular Medicine (10 citations). Massimo Ghizzoni has collaborated with scholars based in Netherlands, Poland and Ireland. Frequent co-authors include Frank J. Dekker, Hidde J. Haisma, Harm Maarsingh, André Boltjes, Tielong Gao, Jiang Wu, Rosalina Wisastra, Chris de Graaf, Adriaan J. Minnaard and Katarzyna Piwocka. Their work appears in journals such as Bioorganic & Medicinal Chemistry, European Journal of Medicinal Chemistry, APOPTOSIS, Anti-Cancer Agents in Medicinal Chemistry and Drug Discovery Today.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.